Clive A. Prestidge
Mawson Lakes Campus, Mawson Lakes
Adelaide, SA 5095, Australia
Adelaide, SA 5095, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 198 publications
Optimizing delivery to the gastrointestinal tract: a mechanistic approach to nutraceutical design and development.
Journal: Expert opinion on drug delivery
Published: August 15, 2026
Engineering controlled antimicrobial delivery across biofilm matrix barriers: mechanics, transport and nanocarrier design.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 12, 2026
Pegylation modulates ApoE association and hepatic accumulation of DC-Chol-based nanoparticles through steric exclusion.
Journal: International journal of pharmaceutics
Published: May 27, 2026
Liquid crystalline nanoparticles for co-delivery of gentamicin and cinnamaldehyde: enhancing antibiofilm efficacy against Pseudomonas aeruginosa via quorum sensing inhibition.
Journal: International journal of pharmaceutics
Published: May 22, 2026
Oral delivery of topoisomerase I inhibitors: From biopharmaceutical barriers to clinical translation.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 05, 2026
Bio-derived solvents for in situ forming implants.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 16, 2026
Exploring the Impact of Lipid Structure and Composition on the Digestion of Next-Generation Meat and Dairy Analogues.
Journal: Foods (Basel, Switzerland)
Published: January 27, 2026
The resilient microbiome: how baseline gut microbial composition influences response to cancer treatment.
Journal: Critical reviews in microbiology
Published: January 01, 2026
Overcoming the oral delivery challenges of venetoclax: advancing a clinically improved Bcl-2 inhibitor.
Journal: Drug delivery and translational research
Published: November 22, 2025
Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide delivery.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 04, 2025
Last Updated: 09/26/2026